Supreme Court: Imminent Death Not Required For a Statement to Qualify as Dying Declaration  ||  SC: HC Cannot Grant Pre-Arrest Bail Without Quashing FIR; Accused Must Approach Sessions Court First  ||  SC: Agreed Interest Rate Cannot Be Challenged as Exorbitant; Arbitrator Cannot Override Contract  ||  SC: Agreed Interest Rate Cannot Be Challenged as Exorbitant; Arbitrator Cannot Override Contract  ||  SC: GST Exemption on Residential Lease Applies When Building is Sub-Leased for Hostel/PG Use  ||  Rajasthan High Court: Universities Cannot Retain Students’ Original Documents for Pending Fees  ||  NCLT: Damages from Contractual Disputes Cannot Form Basis for Initiating Insolvency Proceedings  ||  Del HC: Pre-SCN Consultation is Unnecessary in Large-Scale GST Fraud Cases with Complex Transactions  ||  Calcutta HC: Unilaterally Appointed Arbitrator Violates Natural Justice and Sets Aside the Award  ||  Raj HC Upholds Padmesh Mishra’s AAG Appointment, Noting Advocacy Skill isn’t Tied to Experience    

Search Results for Tag : Glenmark

News

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets(22.12.2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty P.....

Tags : Glenmark Pharmaceuticals Inc, Forest Laboratories, LLC, Forest Laboratories Holdings, , Royalty Pharma Collection Trust



Judgments

Delhi High Court rules in favour of Merck for its diabetes drug(07.10.2015)

The Delhi High Court restrained Glenmark from selling any drug containing Sitagliptin or its derivate. Sitagliptin is the active ingredient used in ‘J.....

Tags : Glenmark, merck, patent, diabetes



Delhi HC Restrains Glenmark Pharmaceuticals from Manufacturing, Selling Zita and Zita-Met(07.10.2015)

Delhi High Court has restrained Glenmark Pharmaceuticals, an Indian firm, from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met, sa.....

Tags : Delhi High Court,Glenmark Pharmaceuticals, Merck Sharp and Dohme, patent



Roche, Glenmark Settle Patent Dispute Over Tarceva(04.01.2016)

Swiss pharma firm Roche and India's Glenmark Pharmaceuticals have settled an out-of-court patent litigation over the former's lung cancer drug erlotin.....

Tags : Roche, Glenmark , Tarceva , Patent



Disclaimer | Copyright 2025 - All Rights Reserved